Cargando…

The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway

Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcri...

Descripción completa

Detalles Bibliográficos
Autores principales: Viegas, Marcelo H., Gehring, Niels H., Breit, Stephen, Hentze, Matthias W., Kulozik, Andreas E.
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2007
Materias:
RNA
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1935013/
https://www.ncbi.nlm.nih.gov/pubmed/17586820
http://dx.doi.org/10.1093/nar/gkm461
_version_ 1782134364930310144
author Viegas, Marcelo H.
Gehring, Niels H.
Breit, Stephen
Hentze, Matthias W.
Kulozik, Andreas E.
author_facet Viegas, Marcelo H.
Gehring, Niels H.
Breit, Stephen
Hentze, Matthias W.
Kulozik, Andreas E.
author_sort Viegas, Marcelo H.
collection PubMed
description Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcriptional mechanisms of gene regulation. Recently, NMD efficiency has been shown to vary between cell types and individuals thus implicating NMD as a modulator of genetic disease severity. We have now specifically analysed the molecular mechanism of variable NMD efficiency and first established an assay system for the quantification of NMD efficiency, which is based on carefully validated cellular NMD target transcripts. In a HeLa cell model system, NMD efficiency is shown to be remarkably variable and to represent a stable characteristic of different strains. In one of these strains, low NMD efficiency is shown to be functionally related to the reduced abundance of the exon junction component RNPS1. Furthermore, restoration of functional RNPS1 expression, but not of NMD-inactive mutant proteins, also restores efficient NMD in this model. We conclude that cellular concentrations of RNPS1 can modify NMD efficiency and propose that cell type specific co-factor availability represents a novel principle that controls NMD.
format Text
id pubmed-1935013
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-19350132007-08-07 The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway Viegas, Marcelo H. Gehring, Niels H. Breit, Stephen Hentze, Matthias W. Kulozik, Andreas E. Nucleic Acids Res RNA Nonsense-mediated mRNA decay (NMD) is a molecular pathway of mRNA surveillance that ensures rapid degradation of mRNAs containing premature translation termination codons (PTCs) in eukaryotes. NMD has been shown to also regulate normal gene expression and thus emerged as one of the key post-transcriptional mechanisms of gene regulation. Recently, NMD efficiency has been shown to vary between cell types and individuals thus implicating NMD as a modulator of genetic disease severity. We have now specifically analysed the molecular mechanism of variable NMD efficiency and first established an assay system for the quantification of NMD efficiency, which is based on carefully validated cellular NMD target transcripts. In a HeLa cell model system, NMD efficiency is shown to be remarkably variable and to represent a stable characteristic of different strains. In one of these strains, low NMD efficiency is shown to be functionally related to the reduced abundance of the exon junction component RNPS1. Furthermore, restoration of functional RNPS1 expression, but not of NMD-inactive mutant proteins, also restores efficient NMD in this model. We conclude that cellular concentrations of RNPS1 can modify NMD efficiency and propose that cell type specific co-factor availability represents a novel principle that controls NMD. Oxford University Press 2007-07 2007-06-22 /pmc/articles/PMC1935013/ /pubmed/17586820 http://dx.doi.org/10.1093/nar/gkm461 Text en © 2007 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle RNA
Viegas, Marcelo H.
Gehring, Niels H.
Breit, Stephen
Hentze, Matthias W.
Kulozik, Andreas E.
The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
title The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
title_full The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
title_fullStr The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
title_full_unstemmed The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
title_short The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway
title_sort abundance of rnps1, a protein component of the exon junction complex, can determine the variability in efficiency of the nonsense mediated decay pathway
topic RNA
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1935013/
https://www.ncbi.nlm.nih.gov/pubmed/17586820
http://dx.doi.org/10.1093/nar/gkm461
work_keys_str_mv AT viegasmarceloh theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT gehringnielsh theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT breitstephen theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT hentzematthiasw theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT kulozikandrease theabundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT viegasmarceloh abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT gehringnielsh abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT breitstephen abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT hentzematthiasw abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway
AT kulozikandrease abundanceofrnps1aproteincomponentoftheexonjunctioncomplexcandeterminethevariabilityinefficiencyofthenonsensemediateddecaypathway